CD40L association with protection from severe malaria

Genes and Immunity

Volumn 3, Issue 5, 2002, Pages 286-291

  Sabeti, P ^a,c   Usen, S ^b   Farhadian, S ^a   Jallow, M ^b,d   Doherty, T ^b   Newport, M ^b   Pinder, M ^b   Ward, R ^c   Kwiatkowski, Dominic ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Royal Victoria Teaching Hospital Gambia   (Gambia)

Author keywords

CD40L; Severe malaria

Indexed keywords

CD40 LIGAND; DNA; GLYCOPROTEIN; IMMUNOGLOBULIN CLASS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CHIMPANZEE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA FLANKING REGION; EXON; FEMALE; GAMBIA; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEMIZYGOSITY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LYMPHOCYTE PROLIFERATION; MALARIA; MALE; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RISK REDUCTION; X CHROMOSOME; ALLELE; ANIMAL; CASE CONTROL STUDY; GENE FREQUENCY; GENETICS; HAPLOTYPE; IMMUNOLOGY; MALARIA FALCIPARUM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAN TROGLODYTES; PROMOTER REGION;

PAN TROGLODYTES;

ALLELES; ANIMALS; BASE SEQUENCE; CASE-CONTROL STUDIES; CD40 LIGAND; CHROMOSOMES, HUMAN, X; DNA; FEMALE; GAMBIA; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MALE; MOLECULAR SEQUENCE DATA; PAN TROGLODYTES; PHENOTYPE; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 0036692110     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363877     Document Type: Article

References (27)

1. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406-411.
2. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 1992; 3: 101-121.
3. Levy J, Espanol-Boren T, Thomas C et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131: 47-54.
4. Gauchat JF, Henchoz S, Fattah D et al. CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 1995; 25: 863-865.
5. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 1995; 154: 4996-5010.
6. Pinchuk LM, Klaus SJ, Magaletti DM, Pinchuk GV, Norsen JP, Clark EA. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 1996; 157: 4363-4370.
7. Kornbluth RS. The emerging role of CD40 ligand in HIV infection. J Leukoc Biol 2000; 68: 373-382.
8. Hill AV. The immunogenetics of resistance to malaria. Proc Assoc Am Physicians 1999; 111: 272-277.
9. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510.
10. Hill AV, Elvin J, Willis AC et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360: 434-439.
11. Kwiatkowski D. Genetic susceptibility to malaria getting complex. Curr Opin Genet Dev 2000; 10: 320-324.
12. Karpusas M, Hsu YM, Wang JH et al. 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995; 3: 1426.
13. Miller RD, Taillon-Miller P, Kwok PY. Regions of low single-nucleotide polymorphism incidence in human and orangutan Xq: deserts and recent coalescences. Genomics 2001; 71: 78-88.
14. Shimadzu M, Nunoi H, Terasaki H et al. Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome. Biochim Biophys Acta 1995; 1260: 67-72.
15. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67: 2-17.
16. Tsytsykova AV, Tsitsikov EN, Geha RS. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem 1996; 271: 3763-3770.
17. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-4884.
18. Hartl DL, Clark AG. Principles of Population Genetics. 3rd edn. Sinauer Associates: Sunderland, Mass, 1997.
19. Anagnostopoulos T, Green PM, Rowley G, Lewis CM, Giannelli F. DNA variation in a 5-Mb region of the X chromosome and estimates of sex-specific/type-specific mutation rates. Am J Hum Genet 1999; 64: 508-517.
20. Cargill M, Altshuler D, Ireland J et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes [published erratum appears in Nat Genet 1999; 23: 373]. Nat Genet 1999; 22: 231-238.
21. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info: a general-purpose microcomputer program for public health information systems. Am J Prev Med 1991; 7: 178-182.
22. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
23. Schaid DJ. Transmission disequilibrium, family controls, and great expectations. Am J Hum Genet 1998; 63: 935-941.
24. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048.
25. Kutsche K, Yntema H, Brandt A et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat Genet 2000; 26: 247-250.
26. Li W-H. Molecular Evolution. Sinauer Associates: Sunderland, Mass, 1997.
27. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.